Fig. 5: SCAN-B: survival and disease recurrence by CTLA4 expression. | Communications Medicine

Fig. 5: SCAN-B: survival and disease recurrence by CTLA4 expression.

From: High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis

Fig. 5: SCAN-B: survival and disease recurrence by CTLA4 expression.The alternative text for this image may have been generated using AI.

5-year overall survival, recurrence-free interval, and distant recurrence-free interval in patients with CTLA4 expression above and below the cutoffs at the 63rd ((a–c); derived from Oslo1) and the 60th ((d–f); derived from SCAN-B) percentile in the SCAN-B cohort.

Back to article page